Tuberculosis (‎ TB)‎ is, and should be, a curable disease; however, each year significant
numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate …

Tuberculosis (TB) remains an important global health concern, even though it is largely
curable with treatment that is affordable and widely accessible for diagnosed and notified TB …

The World Health Organization (WHO) estimates that 10.4 million persons developed
tuberculosis (TB) worldwide in 2016, corresponding to a global incidence of 140 TB cases …

Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …

In order to support countries in their effort to respond to the challenges posed by the TB
epidemic over the years, WHO has produced and regularly updated guidelines for the …

Background Even though the lives of millions have been saved in the past decades, the
mortality rate in patients with drug-resistant tuberculosis is still high. Different factors are …

BACKGROUND: Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to
treat than drug-susceptible ones, and threaten global progress towards the targets set by the …

The World Health Organization standards for tuberculosis care and management |
European Respiratory Society Skip to main content Main menu Home Current issue ERJ …

BACKGROUND: Despite effective anti-tuberculosis chemotherapy, case-fatality rates of up
to 25% are described in both industrialised and resource-poor settings. An understanding of …

The goal of reducing tuberculosis (TB) mortality in the END TB Strategy can be achieved if
TB deaths are considered predictable and preventable. This will require programs to …